Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: Long-term results

Neurological Sciences

Volumn 22, Issue 1, 2001, Pages 93-94

  Stocchi, F ^a   Vacca, L ^a   De Pandis, M F ^a   Barbato, L ^a   Valente, M ^a   Ruggieri, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DECARBOXYLASE INHIBITOR; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS INFUSION; DOPAMINERGIC SYSTEM; DYSKINESIA; FEMALE; HUMAN; JEJUNUM; LONG TERM CARE; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; SIDE EFFECT;

AGED; APOMORPHINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034939127     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720170062     Document Type: Conference Paper

References (7)

1. Marsden CD et al (1981) Fluctuations of disability in Parkinson's disease - clinical aspects. In: Marsden CD, Fahn S (eds) Neurology 2: movement disorders, 2nd edn. Butterworih Scientific, London, pp 96-122
2. Nutt JG, Obeso JA, Stocchi F (2000) Continuous dopamine-receptor stimulation in advanced Parkinson's disease. Trends Neurosci 23:8109-8115
3. Nutt JG et al (1997) Motor fluctuations during continuous 1-dopa infusion in patients with Parkinson's disease. Mov Disord 12:285-292
4. Frankel JP, Lees AJ, Kempster PA, Stern GM (1990) Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 53:96-101
5. Stocchi F et al (1993) Apomorphine and lisuride infusion: a comparative chronic study. Adv Neurol 60:653-655
6. Gancher ST, Nutt JC, Woodward WR (1995) Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of tolerance. Mov Disord 10:37-43
7. Pietz K et al (1998) Subcutaneous apomorphine in late stage Parkinson's disease: a long-term follow up. J Neurol Neurosurg Psychiatry 65:709-716